Original Research
Published on 13 Dec 2023
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing–remitting multiple sclerosis patients
in Multiple Sclerosis and Neuroimmunology
- 4,080 views
- 8 citations